Detalles de la búsqueda
1.
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
N Engl J Med;
366(26): 2443-54, 2012 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22658127
2.
Bilateral transient osteoporosis of the hip in pregnancy.
J Obstet Gynaecol;
38(3): 415-416, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29022409
3.
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab.
J Clin Oncol;
41(5): 943-954, 2023 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36750016
4.
BMS-986012, an Anti-Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study.
JTO Clin Res Rep;
3(11): 100400, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36275912
5.
BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial.
Cancers (Basel);
14(17)2022 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077617
6.
Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia.
Clin Pharmacokinet;
47(7): 475-85, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18563956
7.
Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy.
J Immunother Cancer;
4: 72, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27879974
8.
Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab.
J Clin Oncol;
33(18): 2013-20, 2015 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25800770
9.
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol;
33(18): 2004-12, 2015 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25897158
10.
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.
J Clin Oncol;
32(10): 1020-30, 2014 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24590637
11.
The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases.
Cancer Chemother Pharmacol;
72(1): 53-64, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23719718
12.
Lack of effect of brivanib on the pharmacokinetics of midazolam, a CYP3A4 substrate, administered intravenously and orally in healthy participants.
J Clin Pharmacol;
52(6): 914-21, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21659627
13.
Lack of food effect on single-dose pharmacokinetics of brivanib, and safety and efficacy following multiple doses in subjects with advanced or metastatic solid tumors.
Cancer Chemother Pharmacol;
68(6): 1377-85, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21461891
14.
Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies.
J Nucl Med;
50(10): 1646-54, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19759105
15.
An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.
J Child Adolesc Psychopharmacol;
19(4): 431-9, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19702495
Resultados
1 -
15
de 15
1
Próxima >
>>